Depression and Anxiety Trial, Recruiting (NCT05897619)

Depression and Anxiety Trial, Recruiting NCT05897619 Sponsor: Weill Medical College of Cornell University Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT05897619 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are female, trans-male, non-binary, gender expansive, or gender questioning, and who are pregnant or carrying a pregnancy
People who are currently pregnant or within 12 months of giving birth
People who are 18 years of age or older
People who are proficient in English
People who have access to a smartphone or other mobile device that can receive text messages (SMS) and complete online surveys and app-based activities
People who are able to participate in phone or secure video calls at various points during the study

Who may not be able to join:

People for whom there are safety concerns at the time of joining the trial, including those who score above zero on a specific depression screening question about self-harm (question 10 of the EPDS), or who have experienced thoughts or behaviours related to suicide or self-harm within the past year
People who currently have a diagnosed substance use disorder
People who have a history of bipolar disorder or a psychotic disorder, or who are currently experiencing symptoms of psychosis or mania

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Andrea Temkin-Yu, Psy.D., Weill Medical College of Cornell University

Phone: ‪(640) 203-8301

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05897619

Sponsor: Weill Medical College of Cornell University

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: ‪(640) 203-8301

More information: https://clinicaltrials.gov/study/NCT05897619

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are female, trans-male, non-binary, gender expansive, or gender questioning, and who are pregnant or carrying a pregnancy
People who are currently pregnant or within 12 months of giving birth
People who are 18 years of age or older
People who are proficient in English
People who have access to a smartphone or other mobile device that can receive text messages (SMS) and complete online surveys and app-based activities
People who are able to participate in phone or secure video calls at various points during the study

Who may not be able to join:

People for whom there are safety concerns at the time of joining the trial, including those who score above zero on a specific depression screening question about self-harm (question 10 of the EPDS), or who have experienced thoughts or behaviours related to suicide or self-harm within the past year
People who currently have a diagnosed substance use disorder
People who have a history of bipolar disorder or a psychotic disorder, or who are currently experiencing symptoms of psychosis or mania

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Weill Medical College of Cornell University

Registry

ClinicalTrials.gov

Start date

19 September 2023

Est. completion

1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

User Version of the Mobile Application Rating Scale (uMARS) at midpoint; User Version of the Mobile Application Rating Scale (uMARS) at post-intervention; User Version of the Mobile Application Rating Scale (uMARS) at follow-up; Quantitative Feedback Survey of App Feasibility and Acceptability; Quantitative Feedback Survey of App Feasibility and Acceptability; Quantitative Feedback Survey of App Feasibility and Acceptability; Quantitative Feedback Survey of App Feasibility and Acceptability; Quantitative Feedback Survey of App Feasibility and Acceptability; Quantitative Feedback Survey of App...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov